They also suggested that docetaxel resistance is not due to the direct inactivation of docetaxel by CYP1B1 but rather the indirect mechanism of promoting cancer cell survival based on the pro-apoptotic effect of CYP1B1 knockdown in endometrial cancer cells [39]. The gene discussed is CYP1B1; the disease is endometrial cancer.